B / 15 : Estrogens And Antiestrogens Flashcards
What are the natural estrogens and where are they produced?
- Estradiol : produced in ovary
- Estrone and estriol formed in the liver from estradiol, or in the peripheral tissues from androgens
Pharmacological effects of estrogen (6)
- Promotes proliferation (breast, endometrium)
- Female sexual maturation + growth, secondary sex characteristics
- Metabolic and cardiovascular effects
- Enhance blood coagulation
- Activation of stress and SYM systems
- Na retention, edema
Contraindications for estrogens
- Patients with estrogen dependant neoplasms
- Patients with undiagnosed genital bleeding
- Severe liver disease
- Heavy smokers
- History of thromboembolic disorder
Side effects of estrogens (4)
- Increased risk of endometrial carcinoma, breast cancer
- Postmenopausal uterine bleeding
- Increase in migraine frequency
- Cholestasis, gallbladder disease
Estradiol
- MOA
- Effect
- Indication
- Extra
- ROA
- Natural estrogen
- Promote female maturation + decreased bone resorption + increased blood coagulation
- Hormone replacement (hypogonadism, post-menopause), ovarian suppression (contraception, menstrual problems)
- High first pass metabolism
- Oral, transdermal patch, IM, vaginal creams
Ethinylestradiol
- MOA
- Effect
- Extra
- ROA
- Synthetic estrogen
- Accelerate growth, stimulate secondary sex characteristics
- Good oral bioavailability
- Oral, transdermal patch, IM, vaginal cream
(Everything else is same as estrogens)
What are the anti-estrogens? (3)
- Clomifen (SERM)
- Tamoxifen (SERM)
- Raloxifene (SERM)
What does SERM stand for?
Selective estrogen receptor modulator
Clomifen
- MOA
- Effect
- Indication
- SE
- ROA
- Estrogen receptor antagonist in pituitary gland
- Prevents normal negative feedback : increase FSH + LH -> stimulate ovulation
- To induce ovulation and treat infertility
- Hot flashes, ovarian enlargement, multiple pregnancies
- Oral
Tamoxifen
- MOA
- Effect / indication
- SE
- ROA
(- Extra)
- Estrogen receptor ANTAGONIST in breast tissue, but AGONIST in endometrium and bones
- Prophylaxis treatment of breast cancer in post-menopausal women
- Hot flashes, endometrial hyperplasia, polyps, increased risk of endometrial cancer
- Oral
(- can now be replaced by anastrozole, better results)
Raloxifene
- MOA
- Effect
- Indication
- SE
- Extra
- ROA
- Estrogen receptor ANTAGONIST in breast, estrogen receptor AGONIST in bones
- Inhibits osteoclast differentiation
- First line prevention of postmenopausal osteoporosis
- Hot flashes + increased risk of thromboembolic events
- No effect on endometrium : no increased cancer risk
- Oral
What is an example of an estrogen synthesis inhibitor?
Anastrozole
Anastrozole
- MOA
- Effect
- Indication
- SE
- ROA
- Aromatase (non-steroidal) inhibitor
- Prevents conversion of testosterone to estrogen
- Hormone dependant breast cancer in postmenopausal women
- Hot flashes, vaginal dryness, increased risk of osteoporosis, cardiovascular diseases
- Oral